TripleTree Advises Advent International on its Growth Investment in Iodine Software

December 2021
Iodine Software, a leading healthcare AI company, announced a strategic growth investment from Advent International, one of the largest and most experienced global private equity investors. Advent will acquire a significant stake in Iodine in a transaction that values the business at over $1 billion. Bain Capital Ventures and Silversmith Capital Partners, which invested in the Company in 2018, will remain shareholders. 

Read full press release from Iodine Software.
Like most websites we use cookies here, but we don't share your information. By continuing your visit, you accept the use of cookies. Find out more